López-Novoa JM - Search Results

1

Impaired erythropoietin synthesis in chronic kidney disease is caused by alterations in extracellular matrix composition.

Olmos G, Muñoz-Félix JM, Mora I, Müller AG, Ruiz-Torres MP, López-Novoa JM, Rodríguez-Puyol D. Olmos G, et al. J Cell Mol Med. 2018 Jan;22(1):302-314. doi: 10.1111/jcmm.13319. Epub 2017 Aug 30. J Cell Mol Med. 2018. PMID: 28857467 Free PMC article.

2

The role of endoglin in kidney fibrosis.

Muñoz-Felix JM, Oujo B, Lopez-Novoa JM. Muñoz-Felix JM, et al. Expert Rev Mol Med. 2014 Dec 2;16:e18. doi: 10.1017/erm.2014.20. Expert Rev Mol Med. 2014. PMID: 25439793

3

Absence of K-Ras Reduces Proliferation and Migration But Increases Extracellular Matrix Synthesis in Fibroblasts.

Muñoz-Félix JM, Fuentes-Calvo I, Cuesta C, Eleno N, Crespo P, López-Novoa JM, Martínez-Salgado C. Muñoz-Félix JM, et al. J Cell Physiol. 2016 Oct;231(10):2224-35. doi: 10.1002/jcp.25340. Epub 2016 Mar 6. J Cell Physiol. 2016. PMID: 26873620

4

Telomerase deficiency promotes oxidative stress by reducing catalase activity.

Pérez-Rivero G, Ruiz-Torres MP, Díez-Marqués ML, Canela A, López-Novoa JM, Rodríguez-Puyol M, Blasco MA, Rodríguez-Puyol D. Pérez-Rivero G, et al. Free Radic Biol Med. 2008 Nov 1;45(9):1243-51. doi: 10.1016/j.freeradbiomed.2008.07.017. Epub 2008 Jul 30. Free Radic Biol Med. 2008. PMID: 18718525

5

Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy.

Muñoz-Félix JM, López-Novoa JM, Martínez-Salgado C. Muñoz-Félix JM, et al. Kidney Int. 2014 Feb;85(2):319-32. doi: 10.1038/ki.2013.292. Epub 2013 Aug 14. Kidney Int. 2014. PMID: 23945497 Free article.

6

ALK1-Smad1/5 signaling pathway in fibrosis development: friend or foe?

Muñoz-Félix JM, González-Núñez M, López-Novoa JM. Muñoz-Félix JM, et al. Cytokine Growth Factor Rev. 2013 Dec;24(6):523-37. doi: 10.1016/j.cytogfr.2013.08.002. Epub 2013 Sep 13. Cytokine Growth Factor Rev. 2013. PMID: 24055043 Review.

7

ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts.

Muñoz-Félix JM, Perretta-Tejedor N, Eleno N, López-Novoa JM, Martínez-Salgado C. Muñoz-Félix JM, et al. Biochim Biophys Acta. 2014 Jun;1843(6):1111-22. doi: 10.1016/j.bbamcr.2014.02.017. Epub 2014 Mar 1. Biochim Biophys Acta. 2014. PMID: 24594380 Free article.

8

TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?

Muñoz-Félix JM, González-Núñez M, Martínez-Salgado C, López-Novoa JM. Muñoz-Félix JM, et al. Pharmacol Ther. 2015 Dec;156:44-58. doi: 10.1016/j.pharmthera.2015.10.003. Epub 2015 Oct 19. Pharmacol Ther. 2015. PMID: 26493350 Review.

9

Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro.

Muñoz-Félix JM, Cuesta C, Perretta-Tejedor N, Subileau M, López-Hernández FJ, López-Novoa JM, Martínez-Salgado C. Muñoz-Félix JM, et al. Cell Signal. 2016 Sep;28(9):1252-1261. doi: 10.1016/j.cellsig.2016.05.015. Epub 2016 May 18. Cell Signal. 2016. PMID: 27208502

10

Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease.

Perretta-Tejedor N, Muñoz-Félix JM, Düwel A, Quiros-Luis Y, Fernández-Martín JL, Morales AI, López-Hernández FJ, López-Novoa JM, Martínez-Salgado C. Perretta-Tejedor N, et al. Among authors: lopez novoa jm. Acta Physiol (Oxf). 2019 Jun;226(2):e13247. doi: 10.1111/apha.13247. Epub 2019 Jan 18. Acta Physiol (Oxf). 2019. PMID: 30589223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

364 results

Search Page